Literature DB >> 6254450

ACTH therapy in infantile spasms: side effects.

R Riikonen, M Donner.   

Abstract

162 children with infantile spasms were treated with ACTH at the Children's Hospital, Helsinki, and at the Aurora Hospital, Helsinki, during 1960--76. In a large proportion (37%) of the children the treatment caused pronounced side effects, and the mortality was 4.9%. The most common complications were infections: septic infections, pneumonias, and urinary and gastrointestinal infections. Other side effects were arterial hypertension (11), osteoporosis (2), hypokalaemic alkalosis (2), and other marked electrolyte disturbances (10). In children necropsy showed fresh intracerebral haemorrhages. Four children developed oliguria and hyperkalaemia during and after withdrawal of ACTH. One of them had tubular necrosis confirmed by renal biopsy. Infections were significantly more common with large doses (120 units) of ACTH than with small ones (40 units). It is concluded that side effects, even severe ones, are more common during treatment than had been assumed. Careful watch is important before and after treatment. The benefit of very high dosages should also be reconsidered.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6254450      PMCID: PMC1627020          DOI: 10.1136/adc.55.9.664

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  25 in total

1.  [Propulsive petit mal epilepsy and its treatment with hormones].

Authors:  A MATTHES; E MALLMANN-MUEHLBERGER
Journal:  Dtsch Med Wochenschr       Date:  1963-03-01       Impact factor: 0.628

2.  [Standardised ACTH and dexamethasone therapy of convulsions in early childhood. I. Clinical results (author's transl)].

Authors:  I Lagenstein; R P Willig; E Iffland
Journal:  Monatsschr Kinderheilkd       Date:  1978-08

3.  Cytomegalovirus infection and infantile spasms.

Authors:  R Riikonen
Journal:  Dev Med Child Neurol       Date:  1978-10       Impact factor: 5.449

Review 4.  Peptides and behavior.

Authors:  D de Wied
Journal:  Life Sci       Date:  1977-01-15       Impact factor: 5.037

5.  Occurrence of convulsive seizures during treatment of asthma with cortisone acetate.

Authors:  F C LOWELL; W FRANKLIN; H D BEALE; I W SCHILLER
Journal:  N Engl J Med       Date:  1951-01-11       Impact factor: 91.245

6.  [Spastic flexion disorders: clinical and metabolic problems observed during treatment with zinc tetracosactide].

Authors:  L Cret; M David; V Macabéo; A Frédérich; M Jeune
Journal:  Pediatrie       Date:  1976 Jan-Feb

7.  Hypophysectomy, ACTH1-10 and in vitro protein synthesis in rat brain stem slices.

Authors:  M E Reith; P Schotman; W H Gispen
Journal:  Brain Res       Date:  1974-12-13       Impact factor: 3.252

8.  Long-term prognosis of 150 cases of "West syndrome".

Authors:  P M Jeavons; B D Bower; M Dimitrakoudi
Journal:  Epilepsia       Date:  1973-06       Impact factor: 5.864

9.  Effects of cortisol on unit activity in the hypothalamus of the rat.

Authors:  S Feldman; N Dafny
Journal:  Exp Neurol       Date:  1970-06       Impact factor: 5.330

10.  Radioimmunoassay of rat parathyroid hormone in serum and tissue extracts.

Authors:  G K Hargis; E N Bowser; W J Henderson; G A Williams
Journal:  Endocrinology       Date:  1974-06       Impact factor: 4.736

View more
  29 in total

1.  Revised guideline for prescribing vigabatrin in children. Guideline's claim about infantile spasms is not based on appropriate evidence.

Authors:  A L Lux; S W Edwards; J P Osborne; E Hancock; A L Johnson; C R Kennedy; F J O'Callaghan; R W Newton; C M Verity
Journal:  BMJ       Date:  2001-01-27

2.  Pneumocystis carinii pneumonia associated with adrenocorticotropic hormone treatment for infantile spasms.

Authors:  R Shamir; B Z Garty
Journal:  Eur J Pediatr       Date:  1992-11       Impact factor: 3.183

Review 3.  A risk-benefit assessment of treatments for infantile spasms.

Authors:  R Nabbout
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

4.  Hormonal background of the hypertension and fluid derangements associated with adrenocorticotrophic hormone treatment of infants.

Authors:  R Riikonen; O Simell; L Dunkel; P Santavuori; J Perheentupa
Journal:  Eur J Pediatr       Date:  1989-08       Impact factor: 3.183

5.  Effectiveness and Safety of Different Once-Daily Doses of Adrenocorticotropic Hormone for Infantile Spasms.

Authors:  Jinghua Yin; Qianjin Lu; Fei Yin; Ying Wang; Fang He; Liwen Wu; Lifen Yang; Xiaolu Deng; Chen Chen; Jing Peng
Journal:  Paediatr Drugs       Date:  2017-08       Impact factor: 3.022

Review 6.  Recent advances in the pharmacotherapy of infantile spasms.

Authors:  Raili Riikonen
Journal:  CNS Drugs       Date:  2014-04       Impact factor: 5.749

7.  Acute-onset transient hydrocephalus after suspension of ACTH therapy for infantile spasms: a case report.

Authors:  A M Laverda; G Casara; P A Battistella; P Drigo
Journal:  Ital J Neurol Sci       Date:  1984-06

Review 8.  Treatment of Epileptic Encephalopathies: Current State of the Art.

Authors:  Hiroki Nariai; Susan Duberstein; Shlomo Shinnar
Journal:  J Child Neurol       Date:  2017-01-30       Impact factor: 1.987

9.  Cardiac hypertrophy secondary to ACTH treatment in children.

Authors:  D Lang; E Mühler; C Kupferschmid; E Tacke; G von Bernuth
Journal:  Eur J Pediatr       Date:  1984-06       Impact factor: 3.183

10.  Clinical profile and treatment of infantile spasms using vigabatrin and ACTH--a developing country perspective.

Authors:  Shahnaz Ibrahim; Shamshad Gulab; Sidra Ishaque; Taimur Saleem
Journal:  BMC Pediatr       Date:  2010-01-15       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.